ARTICLE | Company News
HTG, Oncologie partner to develop biomarkers
August 10, 2018 6:23 AM UTC
HTG Molecular Diagnostics Inc. (NASDAQ:HTGM) and Oncologie Inc. (Waltham, Mass.) partnered to develop biomarkers associated with Oncologie's immuno-oncology pipeline. The partners declined to disclose details...